Found: 19
Select item for more details and to access through your institution.
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1468920
- By:
- Publication type:
- Article
Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 295, doi. 10.3390/pharmaceutics13020295
- By:
- Publication type:
- Article
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 9, p. 919, doi. 10.3390/ph14090919
- By:
- Publication type:
- Article
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5479, doi. 10.3390/ijms23105479
- By:
- Publication type:
- Article
The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01747-w
- By:
- Publication type:
- Article
WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133165
- By:
- Publication type:
- Article
Current Technologies for RNA-Directed Liquid Diagnostics.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5060, doi. 10.3390/cancers13205060
- By:
- Publication type:
- Article
Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3859, doi. 10.3390/cancers12123859
- By:
- Publication type:
- Article
A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72480-y
- By:
- Publication type:
- Article
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity.
- Published in:
- Cell Death Discovery, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41420-020-0258-3
- By:
- Publication type:
- Article
Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 12, p. 2689, doi. 10.3390/cells9122689
- By:
- Publication type:
- Article
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 3, p. 613, doi. 10.1007/s11060-024-04763-7
- By:
- Publication type:
- Article
A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 169, n. 2, p. 613, doi. 10.1007/s11060-024-04763-7
- By:
- Publication type:
- Article
Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 141, n. 1, p. 31, doi. 10.1007/s11060-018-03017-7
- By:
- Publication type:
- Article
Progenitor cells derived from gene‐engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology.
- Published in:
- Biotechnology Journal, 2022, v. 17, n. 6, p. 1, doi. 10.1002/biot.202100693
- By:
- Publication type:
- Article
Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway.
- Published in:
- Journal of Neurochemistry, 2008, v. 107, n. 5, p. 1284, doi. 10.1111/j.1471-4159.2008.05681.x
- By:
- Publication type:
- Article
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1468920
- By:
- Publication type:
- Article
Muscarinic receptor drug trihexyphenidyl can alter growth of mesenchymal glioblastoma in vivo.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1468920
- By:
- Publication type:
- Article
Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 1707, doi. 10.2147/OTT.S300623
- By:
- Publication type:
- Article